MARIPOSA HEALTH LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8980914 Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the sameJul 27, 04Mar 17, 15[A61K, C07D]
7081256 Quinolinone derivative pharmaceutical compositon and production method thereforJun 17, 02Jul 25, 06[A61K]
6706733 Quinolinone derivative formulation and its production methodJun 24, 02Mar 16, 04[A61K]
6627642 Quinolinone derivative preparations and process for producing the sameMay 08, 01Sep 30, 03[A61K]
6271416 Quinolinone derivative, method for preparing the same, and anti-allergic agentJun 20, 00Aug 07, 01[C07C]
6136822 Quinolinone derivative, method for preparing the same, and anti-allergic agentDec 01, 98Oct 24, 00[A61K, C07D]
6114352 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredientDec 30, 98Sep 05, 00[A61K, C07D]
5942521 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredientJan 16, 97Aug 24, 99[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.